Linkedin co-founder Reid Hoffman has launched a startup with the intention of using AI to fuel drug discovery. He is partnering with author, physician and scientist, Siddhartha Mukherjee, who famously penned The Emperor of All Maladies: A Biography of Cancer.

In January, Mark Zuckerberg announced that Meta’s nine-year-old fact-checking system, which relied in part on third-party organizations, would come to an end. The tech company is instead set to adopt a “community notes” model reminiscent of what is used by Elon Musk ’s X, which relies on users instead of experts to flag misinformation.

The role will see Mr Hoffman interact with LSE students and faculty and participate in events including discussions and workshops during his visits to London.

We’re producing vastly more information than any of us can possibly consume—artificial intelligence may be the key to effectively making use of that data.

In their new book Superagency, LinkedIn co-founder Reid Hoffman and his coauthor Greg Beato argue for an ambitious and optimistic approach to AI, on

LinkedIn founder and venture capitalist Reid Hoffman has just launched drug discovery startup Manas AI, alongside Dr. Siddhartha Mukherjee, an oncologist.

Reid Hoffman said it's important for platforms to have a "learning dialogue" but shouldn't mean more posts like "anti-vax misinformation."